Quadrant Capital Group’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
VPM
VCM
Quadrant Capital Group's TWST Position: Q1 2026 in Review
Quadrant Capital Group reduced its Twist Bioscience (TWST) stake by 18% in Q1 2026, selling an estimated $1.25K and leaving 128 shares worth $6.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2313.
Quadrant Capital Group first reported a position in TWST in Q1 2021 and has held it in 20 quarters since. The position peaked at $12K in Q3 2022. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.
- Quadrant Capital Group held 128 shares of Twist Bioscience worth $6.08K as of Q1 2026.
- Quadrant Capital Group sold 28 Twist Bioscience shares in Q1 2026, an estimated $1.25K.
- Twist Bioscience made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2313 holding.
- Quadrant Capital Group first reported a position in Twist Bioscience in Q1 2021 and has held it in 20 quarters since.
- Quadrant Capital Group's Twist Bioscience position peaked at $12K in Q3 2022.
- 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.